Rozanolixizumab: First Approval

This article summarizes the milestones in the development of rozanolixizumab leading to this first approval for the treatment of gMG in adults who are anti-AChR or anti-MuSK antibody positive.
Source: Drugs - Category: Drugs & Pharmacology Source Type: research